DarkPulse Inc. Announces Plan for an IPO of its Subsidiary, Optilan, on the New York Stock Exchange
We are delighted to announce our intention via @DarkPulseTech to take Optilan public in the United States mid-2022 via an Initial Public Offering (IPO), signaling a new phase in the company’s growth.
We are delighted to announce our intention via @DarkPulseTech to take Optilan public in the United States mid-2022 via an Initial Public Offering (IPO), signalling a new phase in the company’s growth.
DarkPulse Inc. Announces Plan for an IPO of its Subsidiary, Optilan, on the New York Stock Exchange
We are delighted to announce our intention via @DarkPulseTech to take Optilan public in the United States mid-2022 via an Initial Public Offering (IPO), signaling a new phase in the company’s growth.
We are delighted to announce our intention via @DarkPulseTech to take Optilan public in the United States mid-2022 via an Initial Public Offering (IPO), signalling a new phase in the company’s growth.